Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-04 5:14 pm Purchase | 2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 46,501 12.600% | 28,329 (+155.89%) | Filing History |
| 2023-03-06 4:07 pm Sale | 2022-12-31 | 13G | Eterna Therapeutics Inc. ERNA | DENNY GEORGE P III | 30,694 15.600% | -296,505 (-90.62%) | Filing History |
| 2023-01-31 4:05 pm Purchase | 2023-01-31 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 30,152 8.800% | 74 (+0.25%) | Filing History |
| 2022-12-20 4:30 pm Sale | 2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 26,251 7.670% | -113,416 (-81.20%) | Filing History |
| 2022-12-14 4:30 pm Purchase | 2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 37,835 11.050% | 37,835 (New Position) | Filing History |
| 2022-12-05 5:20 pm Sale | 2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 30,078 8.800% | -286,405 (-90.50%) | Filing History |
| 2022-12-02 5:01 pm Purchase | 2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 18,172 5.300% | 18,172 (New Position) | Filing History |
| 2022-03-16 4:30 pm Sale | 2022-03-09 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 19,711 11.400% | -1,333 (-6.33%) | Filing History |
| 2022-02-16 5:15 pm Sale | 2021-12-31 | 13G | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 6,983 4.000% | -5,657 (-44.75%) | Filing History |
| 2021-08-27 5:26 pm Purchase | 2021-08-27 | 13G | Eterna Therapeutics Inc. ERNA | Factor Bioscience Inc. | 15,570 9.000% | 15,570 (New Position) | Filing History |
| 2021-05-26 10:05 am Sale | 2021-05-25 | 13G | Eterna Therapeutics Inc. ERNA | Custard & Pitts Investment Co. LP | 6,132 4.430% | -833 (-11.96%) | Filing History |
| 2021-05-24 1:03 pm Purchase | 2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 15,824 11.400% | 15,824 (New Position) | Filing History |
| 2021-05-18 11:48 am Purchase | 2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA | Custard & Pitts Investment Co. LP | 6,965 5.030% | 6,965 (New Position) | Filing History |
| 2021-05-13 5:00 pm Purchase | 2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA | DENNY GEORGE P III | 16,360 11.800% | 16,360 (New Position) | Filing History |
| 2021-05-13 5:00 pm Purchase | 2021-03-25 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 21,044 15.200% | 21,044 (New Position) | Filing History |
| 2021-05-04 10:37 am Unchanged | 2021-05-03 | 13G | Eterna Therapeutics Inc. ERNA | GENTILE GUY | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-04-30 4:05 pm Purchase | 2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 12,640 9.130% | 12,640 (New Position) | Filing History |
| 2021-03-17 4:30 pm Sale | 2021-03-15 | 13D | NTN BUZZTIME, INC. NTN | Hyperscale Data Inc. GPUS | 81,826 2.750% | -111,230 (-57.62%) | Filing History |
| 2021-03-16 4:30 pm Sale | 2021-03-12 | 13D | NTN BUZZTIME, INC. NTN | Hyperscale Data Inc. GPUS | 193,056 6.490% | -101,944 (-34.56%) | Filing History |
| 2021-02-22 4:30 pm Unchanged | 2021-02-18 | 13D | NTN BUZZTIME, INC. NTN | Hyperscale Data Inc. GPUS | 295,000 9.960% | 0 (Unchanged) | Filing History |